Trial Profile
Phase III trial of cannabidiol (Epidiolex) in paediatric patients with tuberous sclerosis complex
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2015
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary)
- Indications Tuberous sclerosis
- Focus Therapeutic Use
- Sponsors GW Pharmaceuticals
- 29 Apr 2015 New trial record
- 27 Apr 2015 This trial is expected to be initiated in 2015, according to a GW Pharmaceuticals media release.